A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers
NCT04451811
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
OPL-002
Sponsor
Oppilan Pharma Ltd
Collaborators
[object Object]